Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Unknown 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 42Lung Neoplasms 32Head and Neck Neoplasms 24Glioblastoma 24Squamous Cell Carcinoma of Head and Neck 22Breast Neoplasms 21Lymphoma 17Brain Neoplasms 17Rectal Neoplasms 16Prostatic Neoplasms 15Lymphoma, Non-Hodgkin 14Leukemia, Lymphocytic, Chronic, B-Cell 13Leukemia 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Follicular 11Gliosarcoma 11Esophageal Neoplasms 11Central Nervous System Neoplasms 11Adenocarcinoma Of Esophagus 11Pancreatic Neoplasms 10Melanoma 10Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Neoplasm Metastasis 9Multiple Myeloma 9Neoplasms, Plasma Cell 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Acute 8Burkitt Lymphoma 8Sarcoma 7

Interventions

Imatinib Mesylate 23Cyclophosphamide 18fludarabine 17fludarabine phosphate 13Busulfan 12Whole-Body Irradiation 11nilotinib 10Dasatinib 9thymoglobulin 8ponatinib 8Mycophenolic Acid 8Cytarabine 7Antilymphocyte Serum 7peginterferon alfa-2b 6Tacrolimus 6Cyclosporine 6Clofarabine 6Thiotepa 5Stem Cell Transplantation 4Sirolimus 4Rituximab 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Alemtuzumab 4sargramostim 3Interferon-alpha 3Homoharringtonine 3Cord Blood Stem Cell Transplantation 3Bortezomib 3zileuton 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Radiotherapy × Clear all
NCT00176930 2021-01-22

Stem Cell Transplant for Hematological Malignancy

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
330 enrolled 25 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00005986 2017-11-29

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡